158 related articles for article (PubMed ID: 35747957)
1. Luliconazole Topical Dermal Drug Delivery for Superficial Fungal Infections: Penetration Hurdles and Role of Functional Nanomaterials.
Babu CK; Shubhra ; Ghouse SM; Singh PK; Khatri DK; Nanduri S; Singh SB; Madan J
Curr Pharm Des; 2022; 28(20):1611-1620. PubMed ID: 35747957
[TBL] [Abstract][Full Text] [Related]
2. Multipotentiality of Luliconazole against Various Fungal Strains: Novel Topical Formulations and Patent Review.
Mahajan A; Kaur L; Singh G; Dhawan RK; Singh L
Recent Adv Antiinfect Drug Discov; 2021; 16(3):182-195. PubMed ID: 34766898
[TBL] [Abstract][Full Text] [Related]
3. Luliconazole-loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections.
Baghel S; Nair VS; Pirani A; Sravani AB; Bhemisetty B; Ananthamurthy K; Aranjani JM; Lewis SA
Dermatol Ther; 2020 Nov; 33(6):e13959. PubMed ID: 32618400
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of topically used luliconazole vs. terbinafine 1% creams.
Gnat S; Dyląg M; Łagowski D; Zielinski J
Mycoses; 2021 Aug; 64(8):967-975. PubMed ID: 33884673
[TBL] [Abstract][Full Text] [Related]
5. Does skin permeation kinetics influence efficacy of topical dermal drug delivery system?: Assessment, prediction, utilization, and integration of chitosan biomacromolecule for augmenting topical dermal drug delivery in skin.
Iyer A; Jyothi VGSS; Agrawal A; Khatri DK; Srivastava S; Singh SB; Madan J
J Adv Pharm Technol Res; 2021; 12(4):345-355. PubMed ID: 34820308
[TBL] [Abstract][Full Text] [Related]
6. A Review of Characteristics, Properties, Application of Nanocarriers and Analytical Methods of Luliconazole.
Dos Santos Porto D; Bajerski L; Donadel Malesuik M; Soldateli Paim C
Crit Rev Anal Chem; 2022; 52(8):1930-1937. PubMed ID: 34011234
[TBL] [Abstract][Full Text] [Related]
7. In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent.
Uchida K; Nishiyama Y; Yamaguchi H
J Infect Chemother; 2004 Aug; 10(4):216-9. PubMed ID: 15365862
[TBL] [Abstract][Full Text] [Related]
8. Luliconazole vesicular based gel formulations for its enhanced topical delivery.
Kaur M; Singh K; Jain SK
J Liposome Res; 2020 Dec; 30(4):388-406. PubMed ID: 31631734
[TBL] [Abstract][Full Text] [Related]
9. Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis.
Scher RK; Nakamura N; Tavakkol A
Mycoses; 2014 Jul; 57(7):389-93. PubMed ID: 24621346
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
Kawai M
Med Mycol J; 2019; 60(3):71-74. PubMed ID: 31474693
[TBL] [Abstract][Full Text] [Related]
11. New Topical Therapeutic Options in the Management of Superficial Fungal Infections.
Zeichner JA
J Drugs Dermatol; 2015 Oct; 14(10 Suppl):s35-41. PubMed ID: 26461833
[TBL] [Abstract][Full Text] [Related]
12. Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review.
Kumar L; Verma S; Bhardwaj A; Vaidya S; Vaidya B
Artif Cells Nanomed Biotechnol; 2014 Feb; 42(1):32-46. PubMed ID: 23452349
[TBL] [Abstract][Full Text] [Related]
13. Tavaborole, Efinaconazole, and Luliconazole: Three New Antimycotic Agents for the Treatment of Dermatophytic Fungi.
Saunders J; Maki K; Koski R; Nybo SE
J Pharm Pract; 2017 Dec; 30(6):621-630. PubMed ID: 27488125
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model.
Ghannoum MA; Long L; Kim HG; Cirino AJ; Miller AR; Mallefet P
Med Mycol; 2010 May; 48(3):491-7. PubMed ID: 20370362
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses.
Koga H; Tsuji Y; Inoue K; Kanai K; Majima T; Kasai T; Uchida K; Yamaguchi H
J Infect Chemother; 2006 Jun; 12(3):163-5. PubMed ID: 16826352
[TBL] [Abstract][Full Text] [Related]
16. Solubility enhancement, formulation development and antifungal activity of luliconazole niosomal gel-based system.
Garg AK; Maddiboyina B; Alqarni MHS; Alam A; Aldawsari HM; Rawat P; Singh S; Kesharwani P
J Biomater Sci Polym Ed; 2021 Jun; 32(8):1009-1023. PubMed ID: 33704008
[TBL] [Abstract][Full Text] [Related]
17. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
18. Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies.
Shokri A; Abastabar M; Keighobadi M; Emami S; Fakhar M; Teshnizi SH; Makimura K; Rezaei-Matehkolaei A; Mirzaei H
J Glob Antimicrob Resist; 2018 Sep; 14():260-265. PubMed ID: 29793051
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of Characteristics of Two Topical Therapeutic Agents for Onychomycosis].
Shimamura T; Miyamae A; Imai A; Hirayanagi K; Iwanaga T; Kubota N; Shibuya K
Med Mycol J; 2016; 57(4):J141-J147. PubMed ID: 27904059
[TBL] [Abstract][Full Text] [Related]
20. Luliconazole for the treatment of fungal infections: an evidence-based review.
Khanna D; Bharti S
Core Evid; 2014; 9():113-24. PubMed ID: 25285056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
